Archives

by in
Entry Author Date Location
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
What Seattle Needs (Part 1): “Semi-Successful” Biotech Companies 10/06/14 Seattle
West Coast Biotech Roundup: Gates, Orexigen, Medivation & More 09/12/14 Seattle
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Igenica Follows Genentech Into Antibody-Linked Cancer Drugs 04/11/14 San Francisco
Seattle Genetics Secures $9,000,000 New Financing Round 01/21/14 Seattle
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
Seattle Genetics Nabs $25M More From AbbVie for Souped Up Antibodies 01/08/14 Seattle
3 Life Sciences Companies That Are Built to Last 12/02/13 National
What Can Washington Do to Revitalize Biotech? Q&A With Gov. Inslee 10/25/13 Seattle
The $100M Club: Where the Major League Life Sciences Companies Are 10/14/13 National
While I Was Away on Denali: NanoString, Mirabilis, Seattle Genetics 07/03/13 Seattle
Bayer Joins with Seattle Genetics in Antibody-Drug Conjugate Deal 06/25/13 Seattle
CytomX Snags $25M From Pfizer to Make Souped-Up Antibodies 06/06/13 San Francisco
ASCO Wrap-Up: Cancer News from the West Coast 06/04/13 National
Biotech in the Belt-Tightening Era: The Photos 04/12/13 Seattle
See Clay Siegall, Kim Popovits, Mitch Gold This Afternoon 04/09/13 Seattle
Adaptive Biotechnologies Reaches Fork in the Road. What to Charge? 04/03/13 Seattle
How to Make the Payers Pay: Join the Xconomy Event April 9 03/26/13 Seattle
Biotech for the Belt-Tightening Era: Last Chance For Early-Bird Tix 03/12/13 Seattle
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
Genentech, ImmunoGen Win FDA OK for Souped-Up Breast Cancer Drug 02/22/13 San Francisco
Blaze Bioscience Caps Off $8.5M Financing, Charges Toward Clinic 02/22/13 Seattle
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
Join Us at “Biotech in the Belt-Tightening Era” April 9 in Seattle 02/14/13 Seattle
Seattle Genetics Gets $138M in First-Year Sales of Cancer Drug 02/12/13 Seattle
Companion Diagnostics for Cancer Drugs Advancing Personalized Medicine 01/31/13 Boston
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
Seattle Genetics, Millennium Cancer Drug Cleared in EU 10/31/12 Seattle
Page 1 of 9 next page »